Psychedelics

Numinus clinic network generated $4.7 million in revenue during Q2 2023, showing a significant increase of 596.9 per cent from the same period last year

Depression impacts 1 in 4 people with cancer and often becomes a debilitating aspect of their diagnosis

The company also partnered with Healing CREI to offer full operational clinics to their licensees

The capsules are GMP certified and will be used in clinical trials and by authorized patients

MGC says it is the first company operating in Slovenia to obtain permission to engage in studies on the psychedelic compound

The commission will be investigating the risks and benefits associated with MDMA-assisted therapy

Eight patients sued the government at the end of July last year over what they believe is a violation of constitutional rights

The company is alleging that Mindset knowingly copied Reunion’s RE104 compound

The state's House of Representatives approved the legislation on Thursday

The company will supply Mind Medicine Australia with the substances, now considered designated therapies in the country

Awakn will also be providing its clinical protocols and training to Portuguese clinicians in a 10-year agreement

This will be the company's fifth research clinic in the United States

Companies are running more MDMA and psilocybin trials after the Australian drug regulation changes

The cartoon-like toadstool is psychoactive, has medicinal properties and lives in a symbiotic relationship with certain trees

The drug will be used to help establish a safe supply for patients in Canada and Australia

Psychiatrists can now prescribe MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression

The AUD$5M study will involve about 160 participants and aims to help combat treatment-resistant depression

The program's creation was inspired by new regulations for psychedelic-assisted therapy in Alberta

The company believes this to be the largest shipment of MDMA the government department has ever approved

The development marks a 'watershed moment for psilocybin research' says the company's CEO

Bill A00114 would legalize adult possession and use of ibogaine, mescaline, psilocybin and psilocin

The under-the-tongue drug candidate will be studied in a Phase II clinical trial prior to commercialization

It also introduces state-regulated 'healing centers' where trained facilitators can offer psychedelic-assisted sessions

Quetzalli will be collaborating with the Mexican charities Ha Ta Tukari and Reserva Natural Rancho Los Ocotes

Two physicians were paid by the provincial government for facilitating the therapy earlier this year

The trial will be held at 7 NHS sites in the U.K. with the NIHR funding 66% of the cost

The notice to stakeholders outlined risk management and consent expectations for the study of psychoactive drugs

The program combines ketamine therapy, medical and therapeutic guidance, wellness classes, and week-by-week holistic programming

The cohort led by TheraPsil will be meeting with parliament members and protesting outside the Centre Block

Revenue mushrooming was attributed to the company's cannabis operations and functional fungi drinks

The bill would reduce 'unreasonably burdensome rules and regulations'

The trial is the first psilocybin study funded by the Canadian Institutes of Health Research (CIHR)

PharmAla will have exclusive rights to resell Mindset's cGMP psilocybin to designated researchers

TripSitter says the acquisition will be 'instrumental' for the future of the company

The non-profit trade association received a high level of interest from multiple branches of government

From psilocybin mushroom cultivators to artists and Indigenous leaders, the conference united a broad range of people

Trial will evaluate the efficacy of synthetic psilocybin drug 'APEX-52' for treating vets with PTSD

The companies say this will be the 'world's first' in-clinic application of VR with psychedelic-assisted therapy

New phase I study will be held at MAC Clinical Research in Manchester, England next year

11th annual conference will feature prominent speakers and artists including Dennis McKenna, Vanessa Le-Fan Yuen and Paul Stamets joining virtually from Florida